245 related articles for article (PubMed ID: 32918641)
21. Access to, and uptake of, antiretroviral therapy in a developing country with high HIV prevalence: a population-based cohort study in rural Uganda, 2004-2008.
Kazooba P; Kasamba I; Baisley K; Mayanja BN; Maher D
Trop Med Int Health; 2012 Aug; 17(8):e49-57. PubMed ID: 22943379
[TBL] [Abstract][Full Text] [Related]
22. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study.
Buregyeya E; Naigino R; Mukose A; Makumbi F; Esiru G; Arinaitwe J; Musinguzi J; Wanyenze RK
BMC Pregnancy Childbirth; 2017 Mar; 17(1):94. PubMed ID: 28320347
[TBL] [Abstract][Full Text] [Related]
23. Understanding implementation barriers in the national scale-up of differentiated ART delivery in Uganda.
Zakumumpa H; Rujumba J; Kwiringira J; Katureebe C; Spicer N
BMC Health Serv Res; 2020 Mar; 20(1):222. PubMed ID: 32183796
[TBL] [Abstract][Full Text] [Related]
24. Acceptability of a Mobile Phone Support Tool (Call for Life Uganda) for Promoting Adherence to Antiretroviral Therapy Among Young Adults in a Randomized Controlled Trial: Exploratory Qualitative Study.
Twimukye A; Bwanika Naggirinya A; Parkes-Ratanshi R; Kasirye R; Kiragga A; Castelnuovo B; Wasswa J; Nabaggala MS; Katabira E; Lamorde M; King RL
JMIR Mhealth Uhealth; 2021 Jun; 9(6):e17418. PubMed ID: 34121665
[TBL] [Abstract][Full Text] [Related]
25. Factors influencing adherence to antiretroviral treatment among adults accessing care from private health facilities in Malawi.
Chirambo L; Valeta M; Banda Kamanga TM; Nyondo-Mipando AL
BMC Public Health; 2019 Oct; 19(1):1382. PubMed ID: 31660947
[TBL] [Abstract][Full Text] [Related]
26. Adherence to antiretroviral and cancer chemotherapy, and associated factors among patients with HIV-cancer co-morbidity at the Uganda Cancer Institute: a cross sectional study.
Achieng C; Bunani N; Kagaayi J; Nuwaha F
BMC Public Health; 2023 Jul; 23(1):1451. PubMed ID: 37507710
[TBL] [Abstract][Full Text] [Related]
27. Barriers and facilitators of antiretroviral therapy (ART) adherence habit formation in Sub-Saharan Africa: Evidence from a qualitative study in Kampala, Uganda.
Stecher C; Palimaru AI; Odiit M; Lunkuse L; Walukaga S; Linnemayr S
Soc Sci Med; 2023 Jan; 317():115567. PubMed ID: 36459789
[TBL] [Abstract][Full Text] [Related]
28. Conducting an ongoing HIV clinical trial during the COVID-19 pandemic in Uganda: a qualitative study of research team and participants' experiences and lessons learnt.
Muwanguzi PA; Kutyabami P; Osingada CP; Nasuuna EM; Kitutu FE; Ngabirano TD; Nankumbi J; Muhindo R; Kabiri L; Namutebi M; Nabunya R; Kiwanuka N; Sewankambo N
BMJ Open; 2021 Apr; 11(4):e048825. PubMed ID: 33883157
[TBL] [Abstract][Full Text] [Related]
29. Differentiated Antiretroviral Therapy Distribution Models: Enablers and Barriers to Universal HIV Treatment in South Africa, Uganda, and Zimbabwe.
Duffy M; Sharer M; Davis N; Eagan S; Haruzivishe C; Katana M; Makina N; Amanyeiwe U
J Assoc Nurses AIDS Care; 2019; 30(5):e132-e143. PubMed ID: 31135515
[TBL] [Abstract][Full Text] [Related]
30. The burden of anxiety among people living with HIV during the COVID-19 pandemic in Pune, India.
Marbaniang I; Sangle S; Nimkar S; Zarekar K; Salvi S; Chavan A; Gupta A; Suryavanshi N; Mave V
BMC Public Health; 2020 Oct; 20(1):1598. PubMed ID: 33097028
[TBL] [Abstract][Full Text] [Related]
31. Barriers to access to antiretroviral therapy by people living with HIV in an indonesian remote district during the COVID-19 pandemic: a qualitative study.
Fauk NK; Gesesew HA; Seran AL; Ward PR
BMC Infect Dis; 2023 May; 23(1):296. PubMed ID: 37147599
[TBL] [Abstract][Full Text] [Related]
32. Social and economic barriers to adherence among patients at Livingstone General Hospital in Zambia.
Moomba K; Van Wyk B
Afr J Prim Health Care Fam Med; 2019 Apr; 11(1):e1-e6. PubMed ID: 31038336
[TBL] [Abstract][Full Text] [Related]
33. Explorative-descriptive study on the effects of COVID-19 on access to antiretroviral therapy services: the case of a teaching hospital in Ghana.
Abraham SAA; Doe PF; Osei Berchie G; Agyare E; Ayisi Addo S; Obiri-Yeboah D
BMJ Open; 2022 May; 12(5):e056386. PubMed ID: 35613780
[TBL] [Abstract][Full Text] [Related]
34. Disparity in HIV Service Interruption in the Outbreak of COVID-19 in South Carolina.
Qiao S; Li Z; Weissman S; Li X; Olatosi B; Davis C; Mansaray AB
AIDS Behav; 2021 Jan; 25(1):49-57. PubMed ID: 32856176
[TBL] [Abstract][Full Text] [Related]
35. Are treatment supporters relevant in long-term Antiretroviral Therapy (ART) adherence? Experiences from a long-term ART cohort in Uganda.
Nakamanya S; Mayanja BN; Muhumuza R; Bukenya D; Seeley J
Glob Public Health; 2019 Mar; 14(3):469-480. PubMed ID: 30146972
[TBL] [Abstract][Full Text] [Related]
36. Examining the relationship between psychological distress and adherence to anti-retroviral therapy among Ugandan adolescents living with HIV.
Mutumba M; Musiime V; Lepkwoski JM; Harper GW; Snow RC; Resnicow K; Bauermeister JA
AIDS Care; 2016 Jul; 28(7):807-15. PubMed ID: 27294696
[TBL] [Abstract][Full Text] [Related]
37. The charms and challenges of antiretroviral therapy in Uganda: the DART experience.
Nyanzi-Wakholi B; Lara AM; Munderi P; Gilks C;
AIDS Care; 2012; 24(2):137-42. PubMed ID: 21777081
[TBL] [Abstract][Full Text] [Related]
38. 'Blood pressure can kill you tomorrow, but HIV gives you time': illness perceptions and treatment experiences among Malawian individuals living with HIV and hypertension.
Hing M; Hoffman RM; Seleman J; Chibwana F; Kahn D; Moucheraud C
Health Policy Plan; 2019 Nov; 34(Supplement_2):ii36-ii44. PubMed ID: 31723966
[TBL] [Abstract][Full Text] [Related]
39. The HIV Care Cascade Among Transgender Women with HIV in Canada: A Mixed-Methods Study.
Lacombe-Duncan A; Bauer GR; Logie CH; Newman PA; Shokoohi M; Kay ES; Persad Y; O'Brien N; Kaida A; de Pokomandy A; Loutfy M
AIDS Patient Care STDS; 2019 Jul; 33(7):308-322. PubMed ID: 31260342
[TBL] [Abstract][Full Text] [Related]
40. What influences uptake and early adherence to Option B+ (lifelong antiretroviral therapy among HIV positive pregnant and breastfeeding women) in Central Uganda? A mixed methods study.
Mukose AD; Bastiaens H; Makumbi F; Buregyeya E; Naigino R; Musinguzi J; Van Geertruyden JP; Wanyenze RK
PLoS One; 2021; 16(5):e0251181. PubMed ID: 33951109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
